Author

admin

Browsing

Those responsible for the fatal attack against two Israeli Embassy employees in Washington, D.C., Wednesday will be prosecuted to the ‘fullest extent of the law,’ according to the White House. 

Yaron Lischinsky and Sarah Milgrim were departing an event at the Capital Jewish Museum Wednesday evening when a gunman opened fire and killed them. The two were slated to get engaged next week in Jerusalem, White House Press Secretary Karoline Leavitt said at a White House press briefing. 

A pro-Palestinian man authorities identified as 30-year-old Elias Rodriguez of Chicago was arrested, according to officials. 

‘The evil of antisemitism must be eradicated from our society,’ Leavitt told reporters Thursday. ‘I spoke to the attorney general this morning. The Department of Justice will be prosecuting the perpetrator responsible for this to the fullest extent of the law. Hatred has no place in the United States of America under President Donald Trump. Everyone here at the White House is praying for the victims, friends and families during this unimaginable time.’

Yaron, born in Israel but who grew up in Germany, has a father who is Jewish. However, his mother is a Christian and the family is considered Christian. Milgrim was an American employee the Israeli embassy employed. 

Leavitt’s comments echo similar sentiments from President Donald Trump and other leaders in the administration, who have asserted that the attack amounts to an act of antisemitism. 

‘These horrible D.C. killings, based obviously on antisemitism, must end, NOW!’ he wrote in a Truth Social post. ‘Hatred and Radicalism have no place in the USA. Condolences to the families of the victims. So sad that such things as this can happen! God Bless You ALL!’

Likewise, Secretary of State Marco Rubio said that those responsible for the attack would encounter consequences. 

‘We condemn in the strongest possible terms the murder of two staff members from the Embassy of Israel in Washington, DC. Our prayers are with their loved ones. This was a brazen act of cowardly, antisemitic violence. Make no mistake: we will track down those responsible and bring them to justice,’ Rubio wrote on X on Thursday.

Additionally, Environmental Protection Agency administrator Lee Zeldin said he met Milgrim in May at his agency’s headquarters. 

‘I just met Sarah two weeks ago in my office at EPA HQ. She struck me as a young woman filled with life and positivity,’ Zeldin said in a post on X. ‘Heartbroken to learn she was one of two tragically murdered last night by a Jew-hating radical screaming ‘Free Palestine’. May Sarah and Yaron rest in peace.’

This post appeared first on FOX NEWS

House Republicans passed President Donald Trump’s ‘one big, beautiful bill’ on Thursday morning, working through overnight committee meetings, last-minute huddles in the speaker’s office and even a last-minute assist from the president. 

But while House GOP leadership preached party unity as they passed The One Big Beautiful Bill Act by just one vote, two House Republican holdouts were unwavering in their concerns about the $36 trillion national debt crisis and ultimately voted ‘no.’ 

Reps. Thomas Massie, R-Ky., and Warren Davidson, R-Ohio, took their concerns to social media on Thursday, telling their constituents exactly why they bucked the Republican Party on Trump’s key legislative agenda. 

‘While I love many things in the bill, promising someone else will cut spending in the future does not cut spending. Deficits do matter and this bill grows them now. The only Congress we can control is the one we’re in. Consequently, I cannot support this big deficit plan. NO,’ Davidson said early this morning before the vote was final. 

Massie responded soon after, telling Davidson he agreed and ‘if we were serious, we’d be cutting spending now, instead of promising to cut spending years from now.’

‘I’d love to stand here and tell the American people, ‘We can cut your taxes and increase spending and everything is going to be just fine.’ But I can’t do that because I’m here to deliver a dose of reality. This bill dramatically increases deficits in the near-term, but promises our government will be fiscally responsible five years from now. Where have we heard that before?’ Massie said on the House floor. 

The Kentucky congressman, who regularly sports a national debt clock pin, presented a bleak reality for Trump’s ‘big, beautiful bill’ on Thursday as most Republican holdouts rallied behind the final manager’s amendment. ‘This bill is a debt bomb ticking,’ Massie said. 

When White House Press Secretary Karoline Leavitt was asked about Massie and Davidson voting against the bill, she said the president believes they should be primaried. 

‘I don’t think he likes to see grandstanders in Congress. What’s the alternative? I would ask those members of Congress. Did they want to see a tax hike? Did they want to see our country go bankrupt? That’s the alternative by them trying to vote ‘no.’ The president believes the Republican Party needs to be unified,’ Leavitt said. 

Massie, who has been campaigning on Trump calling him a grandstander, even fundraised on Leavitt’s comments, writing on X, ‘The big beautiful bill has issues. I chose to vote against it because it’s going to blow up our debt. For voting on principle, I now have the President AND his press Secretary campaigning against me from the White House podium. Can you help me by donating?’

Former Rep. Bob Good, R-Va., who served as Chair of the House Freedom Caucus, has spoken out against the country’s debt crisis amid House negotiations, piled on the national debt criticism on Thursday, writing, ‘The Big Ugly Truth is that the Big Ugly Bill will push the Big Ugly Debt over $60 trillion.’

Good found himself out of the job when he lost the Republican primary to now-Rep. John McGuire of Virginia last year. 

He was one of just a handful of House Republicans who endorsed Florida Gov. Ron DeSantis in the 2024 GOP presidential primaries, and then Trump threw his political might behind McGuire.

The One Big Beautiful Bill Act is a multi-trillion-dollar piece of legislation that advances Trump’s agenda on taxes, immigration, energy, defense and the national debt. 

While the bill seeks to make a dent in the national debt crisis by cutting roughly $1.5 trillion in government spending, the United States still has over $36 trillion in debt and has spent $1.05 trillion more than it has collected in fiscal year 2025, according to the Treasury Department.

‘I think the most essential truth in American politics is that nobody actually really cares about the national debt or deficit. It’s too abstract to saturate public sentiment,’ Fox News Digital columnist David Marcus said after the bill passed. 

Fox News Digital’s Elizabeth Elkind contributed to this report. 

This post appeared first on FOX NEWS

: Republican senators John Cornyn and Chuck Grassley and Democratic Sen. Amy Klobuchar are rolling out a bipartisan measure to protect sensitive genetic data in response to privacy concerns sparked by 23andMe’s bankruptcy, Fox News Digital has learned. 

Cornyn, R-Texas; Grassley, R-Iowa; and Klobuchar, D-Minn., are introducing the Don’t Sell My DNA Act, which would safeguard customers’ sensitive genetic information when an entity that maintains data files for bankruptcy. The bill would add genetic information to the definition of ‘personally identifiable information’ in the bankruptcy code. 

Under current law, the bankruptcy code provides protections for personally identifiable information in bankruptcy court proceedings to prevent the possibility of identity theft, harm or other unlawful injury. 

Senate aides told Fox News Digital the current definition of personally identifiable information includes an individual’s name, address, email, phone number, Social Security number, credit card numbers and other information that could be used for identification purposes. 

Those aides said the definition is ‘outdated’ and does not include a reference to genetic information, leaving the information vulnerable.

‘This legislation would solve this problem by updating the definition of ‘personally identifiable information’ in the bankruptcy code to include genetic information,’ a Senate aide said. 

The bill also addresses consumer privacy concerns by having consumers affirmatively consent to the sale or lease of their genetic information after a bankruptcy case commences and requiring companies to provide prior written notice of the use, sale or lease of their genetic information during bankruptcy. 

The bill also requires the trustee or debtor in possession to delete any genetic information not subject to a sale or lease. 

‘Advances in DNA testing have allowed Americans to have unprecedented access to important insights about their genetics, but these companies must have a plan to protect this data in the event of bankruptcy,’ Cornyn told Fox News Digital. 

‘By updating the bankruptcy code, this legislation would safeguard Americans’ sensitive genetic information to ensure it cannot be weaponized against them or made public without their knowledge and consent.’

And Klobuchar said companies ‘have profited off of Americans’ data while consumers have been left in the dark, which is especially concerning in light of reports that 23andMe plans to sell customer genetic data assets to a large pharmaceutical company.’ 

‘This bill will put new protections in place to safeguard Americans’ privacy while giving consumers greater control over how their sensitive health data is shared,’ Klobuchar said. 

Grassley told Fox News Digital consumers should ‘feel confident that any personal nformation shared with a public company isn’t up for grabs when that company files for bankruptcy.’

Grassley told Fox News Digital the bill ‘would fill gaps in current law to help safeguard consumers’ genetic information and ensure Americans’ DNA isn’t treated like any other financial asset.’ 

On Monday, 23andMe announced Regeneron Pharmaceuticals would purchase 23andMe through a bankruptcy auction. 

Senate aides said Regeneron promises to ‘protect consumer information, but the data privacy concerns for future bankruptcies remain.’ 

The genetic testing company 23andMe, once a pioneer in consumer DNA testing, filed for Chapter 11 bankruptcy in March amid financial struggles, a leadership shakeup and growing concerns about the security of its customers’ genetic data.

Regeneron Pharmaceuticals announced it will acquire ‘substantially all’ of genetic testing company 23andMe’s assets.

The pharmaceutical company said it won the court-supervised auction of the genetic testing company, with Regeneron agreeing to pay $256 million for the assets. The auction for 23andMe was part of the Chapter 11 bankruptcy protection it filed in March to arrange a sale of its business.

In its bankruptcy petition, the company estimated a range of $100 million to $500 million for its assets. Estimated liabilities were the same. 

The pharmaceutical company is buying 23andMe’s personal genome service and its health and research services segments, according to 23andMe. 

This post appeared first on FOX NEWS

Department of Agriculture Secretary Brooke Rollins said during a Make America Healthy Again (MAHA) event Thursday that the Trump administration is making history with its approval of numerous waivers that will eliminate junk food from food stamp programs. 

Rollins was in Nebraska on Monday to sign the first alongside Republican Gov. Jim Pillen. She has also signed a waiver for Indiana and Iowa, ‘with half-a-dozen more coming down the line,’ she said.   

‘We are on track to sign multiples of snap waivers to get junk food and sugary drinks out of our food stamp system,’ Rollins said at the Thursday afternoon event, centering around the release of a 69-page report from the Trump administration’s MAHA Commission on how to effect change around childhood chronic disease. 

‘That has never happened before under Republican or Democrat administrations,’ Rollins added. ‘We have never made that happen before. So I am so proud and so grateful.’

On average, 42 million low-income Americans receive food stamp assistance each month, according to the MAHA report released at Thursday’s event. It added that 1 in 5 American children under 17 receive SNAP benefits.

With Nebraska’s waiver, it became the first state in the nation to bar recipients of federal food stamp programs from using the money to buy junk food, soda and other high-sugar items. The exemption will begin as a two-year pilot program, local media reported.

Other GOP-led states, including Texas and West Virginia, have applied for this waiver.

‘SNAP was created to increase access to nutritious food; however, many SNAP purchases are for food with little to no nutritious value,’ Texas GOP Governor Greg Abbott wrote in a letter to Rollins requesting a waiver last week. 

‘Under the Trump administration, for the first time since the program was authorized, states can take steps to eliminate the opportunity to buy junk food with SNAP benefits and assure that taxpayer dollars are used only to purchase healthy, nutritious food.’

West Virginia’s Governor Patrick Morrisey, one of the leaders requesting a waiver, has also been spearheading other MAHA efforts in his state. In March, Morrisey signed House Bill 2354 into law, which made it the first state in the nation to begin prohibiting certain synthetic dyes and additives used in food items sold in the state.

This post appeared first on FOX NEWS

A major prisoner swap between Russia and Ukraine is underway, a senior Ukrainian official said Friday.

The swap is not yet finished, the official told the Associated Press, despite President Donald Trump declaring Friday that Russia and Ukraine completed a ‘major prisoners swap.’ 

The announcements come after Russian and Ukrainian officials took part in direct talks in Turkey last Friday for the first time since the early days of the war, agreeing to release around 1,000 prisoners of war. 

‘A major prisoners swap was just completed between Russia and Ukraine. It will go into effect shortly,’ Trump wrote on Truth Social. ‘Congratulations to both sides on this negotiation. This could lead to something big???’ 

On Thursday, Ukrainian President Volodymyr Zelenskyy wrote on X that ‘I held a meeting on the preparation for an exchange’ and ‘The agreement to release 1,000 of our people from Russian captivity was perhaps the only tangible result of the meeting in Turkey.’ 

Trump had a phone call with Russian President Vladimir Putin on Monday. Following the conversation, Trump said ‘I believe it went very well.’ 

‘Russia and Ukraine will immediately start negotiations toward a Ceasefire and, more importantly, an END to the War. The conditions for that will be negotiated between the two parties, as it can only be, because they know details of a negotiation that nobody else would be aware of,’ Trump said. ‘The tone and spirit of the conversation were excellent. If it wasn’t, I would say so now, rather than later.’ 

Putin, in a statement after the call, also noted that ‘a ceasefire with Ukraine is possible’ but noted that ‘Russia and Ukraine must find compromises that suit both sides.’ 

The Kremlin then said Thursday that both sides had no direct peace talks scheduled. 

‘There is no concrete agreement about the next meetings,’ Kremlin spokesman Dmitry Peskov said, according to the Associated Press. ‘They are yet to be agreed upon.’ 

Fox News Digital’s Morgan Phillips contributed to this report. 

This post appeared first on FOX NEWS

Department of Justice officials on Tuesday charged members or associates of an Armenian organized crime ring with stealing more than $83 million worth of cargo from Amazon by posing as legitimate truck drivers and siphoning off goods destined for the company’s warehouses.

Since at least 2021, at least four people linked to the crime ring carried out a scheme across California to steal truckloads of merchandise, ranging from smart TVs and GE icemakers to SharkNinja vacuums and air fryers, the DOJ alleged.

“At present, Amazon is plagued by recurring thefts of its shipments, which is commonly referred to as ‘cargo theft,’” the complaint says.

Amazon has ramped up its efforts to track and shut down fraudulent, deceptive and illegal activities on its sprawling online store. Eliminating stolen goods is particularly challenging. CNBC reported in 2023 that Amazon suspended dozens of third-party merchants it alleged were selling stolen goods, though many of those sellers claimed they were unknowingly caught in the scheme, putting their businesses at risk of survival.

Amazon isn’t the only retailer afflicted by cargo theft. Experts told CNBC cargo theft-related losses are estimated at close to $1 billion or more a year.

In its complaint, the DOJ said the alleged fraudsters operated four transport carriers — AK Transportation, NBA Holdings, Belman Transport and Markos Transportation — that would obtain contracted freight routes from Amazon Relay, an application used by truckers to obtain work, also referred to as loads.

Each trucker is assigned a load for pickup from a manufacturer’s warehouse to be dropped off at an Amazon facility. Instead, the groups would divert from their designated routes, take a portion of the goods off the trucks and resell them or gift them to associates, prosecutors allege.

In some cases, the “self-styled carriers” would complete their deliveries at an Amazon warehouse several days after they were expected to show up, according to the complaint.

DOJ officials seized the alleged fraudsters’ iPhones and found photos and videos of warehouses lined with boxes of crockpots, Keurig coffee machines, keratin shampoo, Weber grills and other goods.

Amazon teams cooperated with DOJ officials in their investigation, including sharing information about the stolen goods, and details of the alleged fraudsters’ accounts on its online marketplace.

An Amazon spokesperson said in a statement that the company has “zero tolerance” for cargo theft and other forms of organized retail crime. Amazon relies on a mix of internal teams and technologies to prevent ORC schemes. The company has also referred “thousands” of ORC bad actors to law enforcement officials.

“These referrals have resulted in arrests, product seizures and recoveries, and the dismantling of ORC networks in the U.S. and around the world,” they said in a statement.

DOJ officials linked the defendants to a litany of other alleged crimes, including attempted murder, kidnapping, illegal firearm possession and health-care fraud. Several of the 13 defendants are expected to appear in a Los Angeles district court on Tuesday and Wednesday, while one of the defendants appeared in a court in Fort Lauderdale, Florida, on Tuesday and was detained.

This post appeared first on NBC NEWS

As Burger King enters the next phase of its turnaround efforts, the fast-food chain is trying to lure families back to its restaurants with colored Whopper buns and kid-friendly movie partnerships.

Starting Tuesday, the Restaurant Brands International chain will sell new menu items inspired by the “live action” remake of “How to Train Your Dragon.” The collaboration is more than just a one-time partnership — it’s part of Burger King’s broader strategy to lift U.S. sales.

“Where we’re really starting to lean in now that we’ve made some progress in both operations and in our restaurants is on a family-first marketing strategy,” Burger King U.S. and Canada President Tom Curtis told CNBC.

Burger King’s U.S. business has been in turnaround mode for more than 2½ years. After falling behind burger rivals McDonald’s and Wendy’s, the company announced plans to invest hundreds of millions of dollars in a comeback strategy to renovate its restaurants, improve its operations and spend on advertising. The chain even bought its largest U.S. franchisee with the goal of accelerating its restaurant remodels.

“We’re finding that there will be chapters to this as we go through time, and right now is this family strategy chapter, where we’ve done enough work and transformed our restaurant operations to the extent that we’re proud of,” Curtis said. “We’re inviting families back in, and we’re finding that we’re getting better retention when they do come back in.”

Curtis said focusing on families gives Burger King the opportunity to attract customers across age cohorts, from millennials to Generation Alpha, which is roughly defined as people born between 2010 and 2025. Plus, parents’ avid use of social media means that word spreads quickly, giving the approach a leg up compared with targeting a single demographic that isn’t as enthusiastic online.

The limited-time themed menu items include the Dragon Flame-Grilled Whopper, with a red and orange marbled bun; Fiery Dragon Mozzarella Fries, made with Calabrian chili pepper breading; Soaring Strawberry Lemonade; and the Viking’s Chocolate Sundae, with Hershey’s syrup and black and green cookie crumbles.

Movie collaborations aren’t anything new for fast food — or Burger King. It was one of the first fast-food chains to lean into movie tie-ins. In 1977, the chain sold “Star Wars” drinking glasses ahead of the film’s release.

McDonald’s wasn’t far behind, following with a Star Trek-themed Happy Meal two years later, kicking off decades of movie, TV and toy tie-ins aimed at kids. More recently, the Golden Arches’ collaboration with “A Minecraft Movie” across more than 100 markets sold out within two weeks in the U.S., about half the time earmarked for the promotion.

In Burger King’s more recent past, under Curtis’ leadership, the chain has had two major partnerships: one with “Spider-Man: Across the Spider-Verse” two years ago and another with the Addams Family franchise, timed for Halloween last year.

Both of those menus featured Whoppers with thematic, colored buns, dyed using natural colorants, like beet juice or ube.

“Not having artificial dyes and colors is something that’s been important to us for a while,” Curtis said.

Burger King use of natural dyes comes as artificial food dyes have come under fire from health-concerned parents. Following a push from Health and Human Services Secretary Robert F. Kennedy Jr., the Food and Drug Administration recently announced plans to phase out the use of petroleum-based synthetic dyes in food and drinks.

The two previous collaborations also were Burger King’s top-selling Whopper innovations, based on the number sold, according to Curtis.

“What we found in the Addams Family promotion specifically was, as we dug into the property, traffic was fairly flat, but sales were up,” he said, attributing the sales growth to families, which have a higher average check than a solo diner or a couple.

The expected sales lift from the “How to Train Your Dragon” menu comes at a crucial time for Burger King.

In its most recent quarter, the company’s comeback stumbled. The chain’s U.S. same-store sales slid 1.1%, mirroring an industrywide slump as fears about the economy and bad weather kept diners at home.

But Curtis is confident that Burger King is on the right track, pointing to the chain’s relative outperformance compared with its two biggest competitors: McDonald’s and Wendy’s.

“I know that they’re scrambling, and sometimes, frankly, copying some of the things that we do, which, you know, plagiarism is the sincerest form of flattery,” he said. “When we see them doing that, it gives us more conviction to stay on course.”

When the live-action version of “How to Train Your Dragon” hits theaters on June 13, it’s expected to be one of the summer’s big blockbusters. After all, the animated trilogy has grossed more than $1.6 billion worldwide.

Burger King has similar expectations for its menu tie-in.

The past success of the Spider-Verse and Addams Family menu items pushed Burger King to “dramatically” up its forecast for the “How to Train Your Dragon” menu, according to Curtis. And Burger King is also planning on changing its advertising strategy, which could drastically increase demand for the Dragon Flamed-Grilled Whoppers.

“In the past, we would just kind of associate ourselves with the movie property, but we wouldn’t necessarily advertise the association — you’d just see it and hear about it in social media,” Curtis said.

The promotion is supposed to run through early July, but in case Burger King burns through its supply in just three weeks, the chain is prepared to monitor what locations have run out of the menu items. That’s a lesson it learned during its Spider-Verse promotion, when it had to launch a tracker on its website to help customers find the coveted Whopper.

As it learns from every experience, Burger King is planning to dive deeper into franchise partnerships, betting that the extra effort will drive long-term loyalty for the brand.

“We’re doing a couple more of them than we have in the past,” Curtis said. “We’ve got one toward the end of the year that we’re very, very excited about … and we’re getting some lined up for next year as well. In every one of those, we’ll go all in.”

Disclosure: Comcast owns CNBC and Universal Studios, the producer and distributor of “How to Train Your Dragon.”

This post appeared first on NBC NEWS

It took six months, countless hours on hold and intervention from state regulators before Sue Cover says she finally resolved an over $1,000 billing dispute with UnitedHealthcare in 2023.

Cover, 46, said she was overbilled for emergency room visits for her and her son, along with a standard ultrasound. While Cover said her family would eventually have been able to pay the sum, she said it would have been a financial strain on them.

Cover, a San Diego benefits advocate, said she had conversations with UnitedHealthcare that “felt like a circular dance.” Cover said she picked through dense policy language and fielded frequent calls from creditors. She said the experience felt designed to exhaust patients into submission.

“It sometimes took my entire day of just sitting on the phone, being on hold with the hospital or the insurance company,” Cover said.

Cover’s experience is familiar to many Americans. And it embodies rising public furor toward insurers and in particular UnitedHealthcare, the largest private health insurer in the U.S., which has become the poster child for problems with the U.S. insurance industry and the nation’s sprawling health-care system.

The company and other insurers have faced backlash from patients who say they were denied necessary care, providers who say they are buried in red tape and lawmakers who say they are alarmed by its vast influence.

UnitedHealthcare in a statement said it is working with Cover’s provider to “understand the facts of these claims.” The company said it is “unfortunate that CNBC rushed to publish this story without allowing us and the provider adequate time to review.” CNBC provided the company several days to review Cover’s situation before publication.

Andrew Witty, CEO of UnitedHealthcare’s company, UnitedHealth Group, stepped down earlier this month for what the company called “personal reasons.” Witty had led the company through the thick of public and investor blowback. The insurer also pulled its 2025 earnings guidance this month, partly due to rising medical costs, it said.

UnitedHealth Group is by far the biggest company in the insurance industry by market cap, worth nearly $275 billion. It controls an estimated 15% of the U.S. health insurance market, serving more than 29 million Americans, according to a 2024 report from the American Medical Association. Meanwhile, competitors Elevance Health and CVS Health control an estimated 12% of the market each.

It’s no surprise that a company with such a wide reach faces public blowback. But the personal and financial sensitivity of health care makes the venom directed at UnitedHealth unique, some experts told CNBC.

Shares of UnitedHealth Group are down about 40% this year following a string of setbacks for the company, despite a temporary reprieve sparked in part by share purchases by company insiders. In the last month alone, UnitedHealth Group has lost nearly $300 billion of its $600 billion market cap following Witty’s exit, the company’s rough first-quarter earnings and a reported criminal probe into possible Medicare fraud.

In a statement about the investigation, UnitedHealth Group said, “We stand by the integrity of our Medicare Advantage program.”

Over the years, UnitedHealthcare and other insurers have also faced numerous patient and shareholder lawsuits and several other government investigations.

UnitedHealth Group is also contending with the fallout from a February 2024 ransomware attack on Change Healthcare, a subsidiary that processes a significant portion of the country’s medical claims.

More recently, UnitedHealthcare became a symbol for outrage toward insurers following the fatal shooting of its CEO, Brian Thompson, in December. Thompson’s death reignited calls to reform what many advocates and lawmakers say is an opaque industry that puts profits above patients.

The problems go deeper than UnitedHealth Group: Insurers are just one piece of what some experts call a broken U.S. health-care system, where many stakeholders, including drugmakers and pharmacy benefit managers, are trying to balance patient care with making money. Still, experts emphasized that insurers’ cost-cutting tactics — from denying claims to charging higher premiums — can delay or block crucial treatment, leave patients with unexpected bills, they say, or in some cases, even mean the difference between life and death.

In a statement, UnitedHealthcare said it is unfortunate that CNBC appears to be drawing broad conclusions based on a small number of anecdotes.”

Frustration with insurers is a symptom of a broader problem: a convoluted health-care system that costs the U.S. more than $4 trillion annually.

U.S. patients spend far more on health care than people anywhere else in the world, yet have the lowest life expectancy among large, wealthy countries, according to the Commonwealth Fund, an independent research group. Over the past five years, U.S. spending on insurance premiums, out-of-pocket co-payments, pharmaceuticals and hospital services has also increased, government data show.

While many developed countries have significant control over costs because they provide universal coverage, the U.S. relies on a patchwork of public and private insurance, often using profit-driven middlemen to manage care, said Howard Lapin, adjunct professor at the University of Illinois Chicago School of Law.

But the biggest driver of U.S. health spending isn’t how much patients use care — it’s prices, said Richard Hirth, professor of health management and policy at the University of Michigan.

There is “unbelievable inflation of the prices that are being charged primarily by hospitals, but also drug companies and other providers in the system,” said Sabrina Corlette, co-director of the Center on Health Insurance Reforms at Georgetown University.

Lapin said factors such as overtreatment, fraud, health-care consolidation and administrative overhead raise costs for payers and providers, who then pass those on through higher prices. U.S. prescription drug prices are also two to three times higher than those in other developed countries, partly due to limited price regulation and pharmaceutical industry practices such as patent extensions.

While patients often blame insurers, the companies are only part of the problem. Some experts argue that eliminating their profits wouldn’t drastically lower U.S. health-care costs.

Still, UnitedHealthcare and other insurers have become easy targets for patient frustration — and not without reason, according to industry experts.

Their for-profit business model centers on managing claims to limit payouts, while complying with regulations and keeping customers content. That often means denying services deemed medically unnecessary, experts said. But at times, insurers reject care that patients need, leaving them without vital treatment or saddled with hefty bills, they added.

Insurers use tools such as deductibles, co-pays, and prior authorization — or requiring approval before certain treatments — to control costs. Industry experts say companies are increasingly relying on artificial intelligence to review claims, and that can sometimes lead to inaccurate denials.

“It’s all part of the same business model — to avoid paying as many claims as possible in a timely fashion,” said Dylan Roby, an affiliate at the UCLA Center for Health Policy Research.

While other private U.S. insurers employ many of the same tactics, UnitedHealth Group appears to have faced the most public backlash due to its size and visibility.

UnitedHealth Group’s market value dwarfs the sub-$100 billion market caps of competitors such as CVS, Cigna and Elevance. UnitedHealth Group booked more than $400 billion in revenue in 2024 alone, up from roughly $100 billion in 2012.

It has expanded into many parts of the health-care system, sparking more criticism of other segments of its business — and the company’s ability to use one unit to benefit another.

UnitedHealth Group grew by buying smaller companies and building them into its growing health-care business. The company now serves nearly 150 million people and controls everything from insurance and medical services to sensitive health-care data.

UnitedHealth Group owns a powerful pharmacy benefit manager, or PBM, called Optum Rx, which gives it even more sway over the market.

PBMs act as middlemen, negotiating drug rebates on behalf of insurers, managing lists of drugs covered by health plans and reimbursing pharmacies for prescriptions. But lawmakers and drugmakers accuse them of overcharging plans, underpaying pharmacies and failing to pass savings on to patients.

Owning a PBM gives UnitedHealth Group control over both supply and demand, Corlette said. Its insurance arm influences what care is covered, while Optum Rx determines what drugs are offered and at what price. UnitedHealth Group can maximize profits by steering patients to lower-cost or higher-margin treatments and keeping rebates, she said.

The company’s reach goes even further, Corlette added: Optum Health now employs or affiliates with about 90,000 doctors — nearly 10% of U.S. physicians — allowing UnitedHealth Group to direct patients to its own providers and essentially pay itself for care.

A STAT investigation last year found that UnitedHealth uses its physicians to squeeze profits from patients. But the company in response said its “providers and partners make independent clinical decisions, and we expect them to diagnose and document patient information completely and accurately in compliance with [federal] guidelines.”

Other insurers, such as CVS and Cigna, also own large PBMs and offer care services. But UnitedHealth Group has achieved greater scale and stronger financial returns.

“I think the company is certainly best in class when it comes to insurers, in terms of providing profits for shareholders,” said Roby. “But people on the consumer side probably say otherwise when it comes to their experience.”

No one knows exactly how often private insurers deny claims, since they aren’t generally required to report that data. But some analyses suggest that UnitedHealthcare has rejected care at higher rates than its peers for certain types of plans.

A January report by nonprofit group KFF found that UnitedHealthcare denied 33% of in-network claims across Affordable Care Act plans in 20 states in 2023, one of the highest rates among major insurers. CVS denied 22% of claims across 11 states, and Cigna denied 21% in eight states.

UnitedHealth did not respond to a request for comment on that report. But in December, the company also pushed back on public criticism around its denial rates, saying it approves and pays about 90% of claims upon submission. UnitedHealthcare’s website says the remaining 10% go through an additional review process. The company says its claims approval rate stands at 98% after that review.

In addition, UnitedHealth Group is facing lawsuits over denials. In November, families of two deceased Medicare Advantage patients sued the company and its subsidiary, alleging it used an AI model with a “90% error rate” to deny their claims. UnitedHealth Group has argued it should be dismissed from the case because the families didn’t complete Medicare’s appeals process.

A spokesperson for the company’s subsidiary, NaviHealth, also previously told news outlets that the lawsuit “has no merit” and that the AI tool is used to help providers understand what care a patient may need. It does not help make coverage decisions, which are ultimately based on the terms of a member’s plan and criteria from the Centers for Medicare & Medicaid Services, the spokesperson said.

Meanwhile, the reported Justice Department criminal probe outlined by the Wall Street Journal targets the company’s Medicare Advantage business practices. In its statement, the company said the Justice Department has not notified it about the reported probe, and called the newspaper’s reporting “deeply irresponsible.”

Inside the company, employees say customers and workers alike face hurdles.

One worker, who requested anonymity for fear of retaliation, said UnitedHealthcare’s provider website often includes doctors listed as in-network or accepting new patients when they’re not, leading to frequent complaints. Management often replies that it’s too difficult to keep provider statuses up to date, the person said.

UnitedHealthcare told CNBC it believes “maintaining accurate provider directories is a shared responsibility among health plans and providers,” and that it “proactively verifies provider data on a regular basis.” The vast majority of all inaccuracies are due to errors or lack of up-to-date information submitted by providers, the company added.

Emily Baack, a clinical administrative coordinator at UMR, a subsidiary of UnitedHealthcare, criticized the length of time it can take a provider to reach a real support worker over the phone who can help assess claims or prior authorization requests. She said the company’s automated phone system can misroute people’s calls or leave them waiting for a support person for over an hour.

But Baack emphasized that similar issues occur across all insurance companies.

She said providers feel compelled to submit unnecessary prior authorization requests out of fear that claims won’t be paid on time. Baack said that leads to a massive backlog of paperwork on her end and delays care for patients.

UnitedHealthcare said prior authorization is “an important checkpoint” that helps ensure members are receiving coverage for safe and effective care.

The company noted it is “continually taking action to simplify and modernize the prior authorization process.” That includes reducing the number of services and procedures that require prior authorization and exempting qualified provider groups from needing to submit prior authorization requests for certain services.

While UnitedHealthcare is not the only insurer facing criticism from patients, Thompson’s killing in December reinforced the company’s unique position in the public eye. Thousands of people took to social media to express outrage toward the company, sharing examples of their own struggles.

The public’s hostile reaction to Thompson’s death did not surprise many industry insiders.

Alicia Graham, co-founder and chief operating officer of the startup Claimable, said Thompson’s murder was “a horrible crime.” She also acknowledged that anger has been bubbling up in various online health communities “for years.”

Claimable is one of several startups trying to address pain points within insurance. It’s not an easy corner of the market to enter, and many of these companies, including Claimable, have been using the AI boom to their advantage.

Claimable, founded in 2024, said it helps patients challenge denials by submitting customized, AI-generated appeal letters on their behalf. The company can submit appeals for conditions such as migraines and certain pediatric and autoimmune diseases, though Graham said it is expanding those offerings quickly.

Many patients aren’t aware that they have a right to appeal, and those who do can spend hours combing through records to draft one, Graham said. If patients are eligible to submit an appeal letter through Claimable, she said they can often do so in minutes. Each appeal costs users $39.95 plus shipping, according to the company’s website.

“A lot of patients are afraid, a lot of patients are frustrated, a lot of patients are confused about the process, so what we’ve tried to do is make it all as easy as possible,” Graham told CNBC.

Some experts have warned about the possibility of health-care “bot wars,” where all parties are using AI to try to gain an edge.

Mike Desjadon, CEO of the startup Anomaly, said he’s concerned about the potential for an AI arms race in the sector, but he remains optimistic. Anomaly, founded in 2020, uses AI to help providers determine what insurers are and aren’t paying for in advance of care, he said.

“I run a technology company and I want to win, and I want our customers to win, and that’s all very true, but at the same time, I’m a citizen and a patient and a husband and a father and a taxpayer, and I just want health care to be rational and be paid for appropriately,” Desjadon told CNBC.

Dr. Jeremy Friese, founder and CEO of the startup Humata Health, said patients tend to interact with insurers only once something goes wrong, which contributes to their frustrations. Requirements such as prior authorization can be a “huge black box” for patients, but they’re also cumbersome for doctors, he said.

Friese said his business was inspired by his work as an interventional radiologist. In 2017, he co-founded a prior-authorization company called Verata Health, which was acquired by the now-defunct health-care AI startup Olive. Friese bought back his technology and founded his latest venture, Humata, in 2023.

Humata uses AI to automate prior authorization for all specialties and payers, Friese said. The company primarily works with medium and large health systems, and it announced a $25 million funding round in June.

“There’s just a lot of pent-up anger and angst, frankly, on all aspects of the health-care ecosystem,” Friese told CNBC.

UnitedHealth Group also set a grim record last year that did little to help public perception. The company’s subsidiary Change Healthcare suffered a cyberattack that affected around 190 million Americans, the largest reported health-care data breach in U.S. history.

Change Healthcare offers payment and revenue cycle management tools, as well as other solutions, such as electronic prescription software. In 2022, it merged with UnitedHealth Group’s Optum unit, which touches more than 100 million patients in the U.S.

In February 2024, a ransomware group called Blackcat breached part of Change Healthcare’s information technology network. UnitedHealth Group isolated and disconnected the affected systems “immediately upon detection” of the threat, according to a filing with the U.S. Securities and Exchange Commission, but the ensuing disruption rocked the health-care sector.

Money stopped flowing while the company’s systems were offline, so a major revenue source for thousands of providers across the U.S. screeched to a halt. Some doctors pulled thousands of dollars out of their personal savings to keep their practices afloat.

“It was and remains the largest and most consequential cyberattack against health care in history,” John Riggi, the national advisor for cybersecurity and risk at the American Hospital Association, told CNBC.

Ransomware is a type of malicious software that blocks victims from accessing their computer files, systems and networks, according to the Federal Bureau of Investigation. Ransomware groups such as Blackcat, which are often based in countries such as Russia, China and North Korea, will deploy this software, steal sensitive data and then demand a payment for its return.

Ransomware attacks within the health-care sector have climbed in recent years, in part because patient data is valuable and relatively easy for cybercriminals to exploit, said Steve Cagle, CEO of the health-care cybersecurity and compliance firm Clearwater.

“It’s been a very lucrative and successful business for them,” Cagle told CNBC. “Unfortunately, we’ll continue to see that type of activity until something changes.”

UnitedHealth Group paid the hackers a $22 million ransom to try to protect patients’ data, then-CEO Witty said during a Senate hearing in May 2024.

In March 2024, UnitedHealth Group launched a temporary funding assistance program to help providers with short-term cash flow.

The program got off to a rocky start, several doctors told CNBC, and the initial deposits did not cover their mounting expenses.

UnitedHealth Group ultimately paid out more than $9 billion to providers in 2024, according to the company’s fourth-quarter earnings report in January.

Witty said in his congressional testimony that providers would only be required to repay the loans when “they, not me, but they confirm that their cash flow is normalized.”

Almost a year later, however, the company is aggressively going after borrowers, demanding they “immediately repay” their outstanding balances, according to documents viewed by CNBC and providers who received funding. Some groups have been asked to repay hundreds of thousands of dollars in a matter of days, according to documents viewed by CNBC.

A spokesperson for Change Healthcare confirmed to CNBC in April that the company has started recouping the loans.

We continue to work with providers on repayment and other options, and continue to reach out to those providers that have not been responsive to previous calls or email requests for more information,” the spokesperson said.

The pressure for repayment drew more ire toward UnitedHealth Group on social media, and some providers told CNBC that dealing with the company was a “very frustrating experience.”

The vast majority of Change Healthcare’s services have been restored over the last year, but three products are still listed as “partial service available,” according to UnitedHealth’s cyberattack response website.

Witty’s departure and the company’s warning about elevated medical costs, combined with the fallout from Thompson’s murder and the Change Healthcare cyberattack, could mean UnitedHealth faces an uphill battle.

UnitedHealth Group appears to be trying to regain the public’s trust. For example, Optum Rx in March announced plans to eliminate prior authorizations on dozens of drugs, easing a pain point for physicians and patients.

But policy changes at UnitedHealth Group and other insurers may not drastically improve care for patients, health insurance industry experts previously told CNBC.

They said there will need to be structural changes to the entire insurance industry, which will require legislation that may not be high on the priority list for the closely divided Congress.

The spotlight on UnitedHealth Group may only grow brighter in the coming months. The trial date for Luigi Mangione, the man facing federal stalking and murder charges in connection with Thompson’s shooting, is expected to be set in December. Mangione has pleaded not guilty to the charges.

This post appeared first on NBC NEWS

Are you looking to generate consistent weekly income from the stock market?

In this video, Tony Zhang breaks down some of the top income-generating options strategies that traders and investors can use to create a consistent cash flow. Whether you’re just getting started or looking to refine your options trading skills, this is a must-watch for anyone serious about income generation through options.

Tony dives into three of the most effective options strategies:

  • Covered calls
  • Cash-secured puts
  • Credit spreads

But that’s just a start.

Tony demonstrates how to leverage the StockCharts Scan Engine, organize and monitor trading opportunities using ChartLists, and analyze each trade in the OptionsPlay Strategy Center so you can utilize the full power of the tools available to you in the OptionsPlay Add-On for StockCharts.  

This video premiered on May 20, 2025.  

If you regularly follow the SCTR Reports (StockCharts Technical Rank), you’ll notice that some top-ranked stocks aren’t just individual standouts but groupings that call attention to particular sectors, industries, or subgroups within the two.

That’s exactly what happened Tuesday morning. A couple of high-ranking stocks pointed to a growing trend in the thematic subsector of quantum computing.

Quantum Computing Stocks Light Up the SCTR Reports

Occupying the top ranks of the Mid Cap SCTR Top 10 list are quantum computing stocks D-Wave Quantum Inc. (QBTS) and Rigetti Computing, Inc. (RGTI).

FIGURE 1. SCTR REPORTS – MID CAP TOP 10. QBTS and RGTI, occupying the top of the list, signal strength in the quantum computing subsector.

The quantum computing subsector made headlines Tuesday morning, with QBTS leading the charge. 

QBTS Leads on Breakout News and Bullish Technical Scans

QBTS shares surged after the company unveiled Advantage2, its most advanced quantum system to date. A quick look at QBTS’s Symbol Summary showed the stock appearing across multiple bullish technical scans on Tuesday, including New 52-week Highs, P&F Double Top Breakout, and Runaway Gap Ups.

Other quantum names, including RGTI, also saw gains, highlighting growing momentum in the space. 

RGTI Gains Momentum with Unique Technical Setups

RGTI’s Symbol Summary profile revealed a different set of predefined scans, suggesting unique technical setups driving its price action. RGTI was triggered in the P&F Ascending Triple Top Breakout, Elder Bar Turned Blue, and P&F Double Top Breakout predefined scans on Tuesday.

With quantum computing stocks like QBTS and RGTI surging and showing unusually strong technical strength, assessing their investment potential requires more than a few headlines. Comparative strength, broader performance of sectors to which they belong, and the underlying factors shaping their price action are some other factors to consider.

FIGURE 2. PERFCHARTS OF QBTS, RGTI, XLK, AND QQQ. At these levels of outperformance, it becomes difficult to separate justified valuations from pure FOMO. As the PerfCharts comparison shows, RTGI and QBTS stocks are outperforming their sector and broader tech-heavy index. 

Technical Breakout: What to Watch with QBTS’ Next Move

From a technical perspective, does either stock present a favorable structure for a market entry? To evaluate this, let’s start with a daily chart of QBTS.

FIGURE 3. DAILY CHART OF QBTS. An impressive parabolic run, support on the downside is relatively clear.

QBTS broke out above its four-month trading range, shooting up to an all-time high of $17.50 on Tuesday’s session, sending the Relative Strength Index (RSI) deep into overbought territory. The Price Channels identify potential areas of support based on previous swing highs and lows.

If QBTS is overbought because its valuations are too high, then a pullback is likely to follow. Whether you should buy the dip depends on your fundamental thesis, but technically, if you decide to enter a position, consider this:

  • QBTS is likely to find support at the top of its previous range, highlighted in green.
  • If it falls below that, there’s another support range, shaded yellow, that marks another set of minor swing highs in the middle of the previous trading range.
  • Below that, however, is support at a low range, shaded red, where the stock has reversed several times over the last few months. 

However, if QBTS drops into the zone between the yellow and red support levels, it could signal a meaningful loss of momentum and growing weakness in the stock’s trend.

That’s why volume becomes especially important here. Note how volume has risen with each successive surge—an encouraging sign of accumulation that somehow dropped at each price peak. If QBTS holds above the top of its previous range, watch for continued volume support; strong follow-through should be backed by equally strong participation.

RGTI Chart Shows Upside Potential—But With Caution

Now let’s look at the second one up on the SCTR Top 10 list. Here’s a daily chart of RGTI.

FIGURE 4. DAILY CHART OF RGTI. The stock is moving steadily upward, but unlike QBTS, there’s no outstanding catalyst to trigger an immediate and outsize move.

Following a fourth bounce at the $7 support range, RGTI broke above resistance, almost hesitantly, at $11. The Volume-by-Price overlay on the left side of the chart shows heavy trading activity in this range, suggesting it could become a strong support level now that resistance has been broken. The ZigZag line further clarifies the support and resistance levels, helping to visualize the stock’s overall trend structure.

The On Balance Volume (OBV) indicator in the bottom panel reflects steady buying pressure. At the same time, the RSI, currently at 61 and rising, suggests the stock still has room to climb before entering overbought territory. 

If RGTI maintains its upward trajectory, the next meaningful resistance level ahead will be at $16, marking its January high. However, whether it gets there may depend less on chart patterns and more on underlying catalysts.

In other words, is RGTI riding the wave of bullish sentiment in quantum computing stocks, or does it have a meaningful fundamental catalyst driving its move higher? On that note, what about QBTS?

Wall Street Weigh In: Real Catalysts or Quantum Hype?

Be careful. Analysts are cautiously optimistic about both stocks, pointing to real catalysts like RGTI’s government partnerships and QBTS’s Advantage2 launch. However, some on Wall Street caution that recent gains may be driven more by hype than fundamentals, with commercial adoption still a long way off.

Action Steps

  • Monitor the support levels. For QBTS, watch the green zone (prior range top) for dip-buying potential; deeper moves into yellow or red zones may signal weakening momentum.
  • Track volume behavior. Continued surges should be matched with strong volume to confirm trend strength.
  • Stay grounded. If you’re trading, closely follow the technicals. If you’re investing, make sure your thesis includes realistic expectations on commercialization timelines.

At the Close

Quantum computing stocks like QBTS and RGTI are showing impressive momentum, backed by technical strength and growing investor interest. But while the setups look promising, remember to stay disciplined. Monitor support levels, watch volume closely, and don’t lose sight of the long runway ahead for true commercial adoption.


Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your personal and financial situation, or without consulting a financial professional.